Similar articles

• Prognosis of asymptomatic multiple myeloma.

  Alexanian R, Barlogie B, Dixon D. Alexanian R, et al. Arch Intern Med. 1988 Sep;148(9):1963-5. Arch Intern Med. 1988. PMID: 2458080
• [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].

  Lubo-Lesnichenko IF, Bessmel'tsev SS, Abdulkadyrov KM, Blinov MN, Stel'mashenko LV. Lubo-Lesnichenko IF, et al. Ter Arkh. 1996;68(10):28-31. Ter Arkh. 1996. PMID: 9026938 Russian.
• [Prognostic importance of beta-2-microglobulin in multiple myeloma].

  Avilés A, Zepeda G, Guzmán R, Talavera A, García EL, Díaz-Maqueo JC. Avilés A, et al. Rev Invest Clin. 1992 Apr-Jun;44(2):215-20. Rev Invest Clin. 1992. PMID: 1439309 Spanish.
• Prognostic factors and staging in multiple myeloma.

  Fonseca R, San Miguel J. Fonseca R, et al. Hematol Oncol Clin North Am. 2007 Dec;21(6):1115-40, ix. doi: 10.1016/j.hoc.2007.08.010. Hematol Oncol Clin North Am. 2007. PMID: 17996591 Review.
• [Multiple myeloma. Role of prognostic factors and staging in a therapeutic program].

  Bolis S, Bregani ER, Rossini F, Casaroli I, Lanzi E, Maffè P, Baldicchi L, Borin L, Mingozzi S, Tripputi P, et al. Bolis S, et al. Recenti Prog Med. 1994 Jan;85(1):49-55. Recenti Prog Med. 1994. PMID: 8184181 Review. Italian.